# 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer

> **NCT00189657** · PHASE3 · UNKNOWN · sponsor: **Association Européenne de Recherche en Oncologie**

## Conditions studied

- Cancer of the Rectum

## Interventions

- **PROCEDURE:** 5FU/LV Mayo Clinic or LV5FU2
- **PROCEDURE:** LV5FU2 + irinotecan

## Key facts

- **NCT ID:** NCT00189657
- **Lead sponsor:** Association Européenne de Recherche en Oncologie
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189657, "5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00189657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*